NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- via IBN -- AI Maverick Intel, Inc. (OTCID: BINP) (“AI Maverick” or the “Company”) today announces the full rollout of its next-generation prospecting...
NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its audited financial statements for the...
NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced it has engaged Aloba, Awomolo & Partners, a PCAOB-registered accounting firm, as its independent...
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced that it has submitted an application to uplist from the OTC Pink to the OTCQB Venture...
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its financial audits for the fiscal years 2022 and...
NEW YORK CITY, NEW YORK / ACCESSWIRE / January 14, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to provide a corporate update as it looks ahead to a promising year in 2025. The company...
NEW YORK, NY / ACCESSWIRE / January 8, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the generation of over $100,000 in revenue following the signing of a Binding Letter...
NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the signing of a Binding Letter of Intent (LOI) with Vitawin Supplements Ltd. to...
NEW YORK, NY / ACCESSWIRE / November 27, 2024 / Bionoid Pharma (OTC PINK:BINP) unveils AI Maverick's game-changing sales automation in the latest episode of the BizUnLearned Podcast. Discover how this...
NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) - Bionoid Pharma, Inc. ("Bionoid") ("BINP") (OTC Pink:BINP), the new owner of the AI Maverick platform,...